Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

Home  >>  News  >>  Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

On February 19, 2019, Posted by , In News, By ,, , With Comments Off on Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

The new Helmholtz Institute for Translational Oncology (HI-TRON Mainz) aims to develop into one of the world’s leading centres for personalised cancer immunotherapy. This is the ambitious goal of the cooperation partners German Cancer Research Center (DKFZ) and Research Institute for Translational Oncology (TRON gGmbH) at the Johannes Gutenberg University of Mainz. Minister President Malu Dreyer also took part in the official founding ceremony of HI-TRON Mainz.

Original news (in German).

v. l. n. r., vorne: Georg Krausch, Gutenberg Universität Mainz, Christian Elsner, Universitätsmedizin (UM) Mainz, Marion Hahn, UM Mainz, Norbert Pfeiffer, UM Mainz, Ministerpräsidentin Malu Dreyer, Konrad Wolf, Wissenschaftsminister Rheinland-Pfalz, Ugur Sahin, TRON. Hinten: Michael Föhlings, TRON, Dirk Heinz, Helmholtz, Josef Puchta, DKFZ, Veronika von Messling, BMBF, Michael Baumann, DKFZ, Ulrich Förstermann, UM Mainz, Stephan Grabbe, UM Mainz, Christoph Huber, ehem. UM Mainz © Jürgen Arlt / DKFZ

Related Post

Comments are closed.